Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

CAPS Rating: 2 out of 5

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.

Recs

0
Player Avatar getmenews (< 20) Submitted: 12/5/2012 10:26:53 AM : Outperform Start Price: $1.04 CHTP Score: -23.59

re bounder

Featured Broker Partners


Advertisement